Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

Olopatadine HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

53 API Suppliers, 17 USDMF, 9 JDMF, 9 EU WC, 14 KDMF, 15 NDC API, 27 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers, 37 FDA Orange Book, 30 Europe, 11 Canada, 5 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE, SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE, SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 DKSH, 4 Boai NKY Pharmaceuticals Ltd, 1 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 1 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 3 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 4 Microlex e.U, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 3 Roquette, 6 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

36 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 14 Direct Compression, 14 Controlled & Modified Release, 14 Parenteral, 13 Chewable & Orodispersible Aids, 12 Taste Masking, 11 Solubilizers, 10 Granulation, 9 Disintegrants & Superdisintegrants, 7 Thickeners and Stabilizers, 6 Film Formers & Plasticizers, 5 Co-Processed Excipients, 5 Empty Capsules, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Rheology Modifiers, 3 Topical, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Lubricants & Glidants

DIGITAL CONTENT

53 News #PharmaBuzz

53 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 8 Regulatory FDF Prices, 19 Annual Reports

MARKET PLACE

21 APIs, 5 FDF Dossiers

PATENTS & EXCLUSIVITIES

18 US Patents, 1 US Exclusivities, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 Others

5 Others

ANALYTICAL

3 Analytical Methods

3 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Aurore Life Sciences	India	Kolon Life Science Co., Ltd.	20240911-209-J-1704	Olopatadine hydrochloride	2024-09-11	Aurore Pharmaceuticals Private Limited (Unit-1)@Kolon Life Science Co., Ltd.	India	Plot No. 35, 36, 38 to 40, 49 to 51 Phase IV, IDA, Jeedimetla, Hyderabad Telangana Jeedimetla Village, Quthbullapur Mandal, Medchal-Malkajgiri District Pincode 500055, Telangana State India@54, Gipyodosi 1-ro, Daesowon-myeon, Chungju-si, Chungcheongbuk-do
29/11/2025	Curia	U.S.A	Goodwills Co., Ltd.	20210428-209-J-960	Olopatadine hydrochloride	2021-04-28	Curia Spain SAU	Spain	Parque Tecnológico Boecillo, Parcelas 2y 3, Boecillo, 47151 Valladolid, Spain

Olopatadine HCl

Olopatadine HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

53 API Suppliers

17 USDMF

9 JDMF

9 EU WC

14 KDMF

15 NDC API

27 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

15 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

106 FDF Dossiers

37 FDA Orange Book

30 Europe

11 Canada

5 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION/DROPS;OPHTHALMIC - EQ 0.7% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% BASE

SOLUTION/DROPS;OPHTHALMIC - EQ 0.2% BASE

SPRAY, METERED;NASAL - 0.665MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

13 SPI Pharma

3 DKSH

4 Boai NKY Pharmaceuticals Ltd

1 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

1 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

10 BASF

1 Clariant

10 Corel Pharma Chem

1 Finar

6 Gangwal Chemicals

3 Ideal Cures

1 Ingredion Pharma Solutions

10 Kerry

3 Kima Chemical

6 Lonza Capsugel

4 Microlex e.U

2 Novo Excipients

1 Pharmatrans-Sanaq

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

3 Roquette

6 Seppic

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

2 The Dow Chemical Company

1 Ulanqab Kema New Material

EXCIPIENTS BY APPLICATIONS

36 Coating Systems & Additives

31 Fillers, Diluents & Binders

14 Direct Compression

14 Controlled & Modified Release

14 Parenteral

13 Chewable & Orodispersible Aids

12 Taste Masking

11 Solubilizers

10 Granulation

9 Disintegrants & Superdisintegrants

7 Thickeners and Stabilizers

SPRAY, METERED;NASAL - 0.665MG/SPRAY Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons